| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |